79.34
前日終値:
$82.10
開ける:
$81.8
24時間の取引高:
4.95M
Relative Volume:
1.16
時価総額:
$45.74B
収益:
$6.07B
当期純損益:
$1.06B
株価収益率:
43.92
EPS:
1.8063
ネットキャッシュフロー:
$1.34B
1週間 パフォーマンス:
-3.83%
1か月 パフォーマンス:
-8.25%
6か月 パフォーマンス:
+4.05%
1年 パフォーマンス:
+11.45%
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, SYK, MDT, BSX
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EW
Edwards Lifesciences Corp
|
79.34 | 45.74B | 6.07B | 1.06B | 1.34B | 1.8063 |
|
ABT
Abbott Laboratories
|
103.99 | 180.70B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
327.44 | 125.40B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.17 | 102.80B | 20.08B | 2.89B | 3.66B | 1.9391 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-09 | アップグレード | TD Cowen | Hold → Buy |
| 2025-12-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | アップグレード | Jefferies | Hold → Buy |
| 2025-10-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-29 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-04-24 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | アップグレード | Stifel | Hold → Buy |
| 2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
| 2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | Truist | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
| 2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | ダウングレード | Stifel | Buy → Hold |
| 2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 開始されました | Mizuho | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-27 | 繰り返されました | Citigroup | Buy |
| 2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | Stifel | Buy |
| 2022-01-27 | 繰り返されました | UBS | Neutral |
| 2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
| 2021-07-30 | 繰り返されました | Jefferies | Buy |
| 2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
| 2021-07-30 | 繰り返されました | Stifel | Buy |
| 2021-07-30 | 繰り返されました | UBS | Neutral |
| 2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Underperform |
| 2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Outperform |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-09-23 | 開始されました | Piper Jaffray | Overweight |
| 2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Hold |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
Is Edwards Lifesciences (EW) Pricing Look Attractive After Recent Pullback? - simplywall.st
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
What to Expect From Edwards Lifesciences' Next Quarterly Earnings Report - inkl
Vanguard affiliate reports zero holdings in Edwards Lifesciences (NYSE: EW) - Stock Titan
[DEF 14A] Edwards Lifesciences Corp Definitive Proxy Statement - Stock Titan
EW Technical Analysis | Trend, Signals & Chart Patterns | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
SG Americas Securities LLC Grows Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Seilern Investment Management Ltd Has $78.71 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
EW Stock Price, Quote & Chart | EDWARDS LIFESCIENCES CORP (NYSE:EW) - chartmill.com
Central Pacific Bank Trust Division Buys New Holdings in Edwards Lifesciences Corporation $EW - Defense World
Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now? - Yahoo Finance
Edwards Lifesciences Policy Hire Puts Valuation And Returns In Focus - simplywall.st
AIA Group Ltd Sells 314,688 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
S P Trends: Can Edwards Lifesciences Corporation benefit from deglobalization2026 Recap & Fast Moving Market Watchlists - baoquankhu1.vn
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Edwards Beats Heart Valve IP Suit Just Before Trial - Law360
Brevan Howard Capital Management LP Has $3.60 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW) Valuation Check After Recent Share Price Momentum - Yahoo Finance
Edwards Lifesciences Stock Hits Day Low of $81.34 Amid Price Pressure - Markets Mojo
Edwards Lifesciences: More Appeal For The Heart (NYSE:EW) - Seeking Alpha
Edwards Lifesciences Corporation $EW Stock Position Lifted by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Edwards Lifesciences Stock (ISIN: US28176E1082) Faces Headwinds Amid Market Cap Dip and Mixed Analys - AD HOC NEWS
EWEdwards Lifesciences Corp Latest Stock News & Market Updates - Stock Titan
Wellington Management Group LLP Buys 977,933 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Chesapeake Capital Corp IL Makes New $1 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Banque Transatlantique SA Has $2.91 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Hits Day High with Strong 3.21% Intraday Surge - Markets Mojo
Edwards Lifesciences (EW) slips 3.3% as investors digest recent conference remarks and insider-selling filings - Quiver Quantitative
Edwards Lifesciences Corp. Experiences Evaluation Revision Amidst Strong Market Performance - Markets Mojo
Van ECK Associates Corp Reduces Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Stock Up 22.1% in a Year: What's Driving It? - Yahoo Finance
Connor Clark & Lunn Investment Management Ltd. Has $42.22 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Bought by Bank of Montreal Can - MarketBeat
How The Edwards Lifesciences (EW) Story Is Shifting As 2026 Expectations Tighten - Yahoo Finance
WINTON GROUP Ltd Sells 57,665 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Natixis Advisors LLC Grows Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Grantham Mayo Van Otterloo & Co. LLC Acquires New Position in Edwards Lifesciences Corporation $EW - MarketBeat
A Look At Edwards Lifesciences (EW) Valuation As It Exits Critical Care To Focus On Core Heart Therapies - simplywall.st
Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW) - GuruFocus
Edwards Lifesciences (NYSE: EW) brokered cashless option exercise on 03/11/2026 - Stock Titan
Edwards Lifesciences at Leerink Conference: Strategic Growth and Innovation - Investing.com
Edwards Lifesciences Corporation $EW Shares Sold by Swiss National Bank - MarketBeat
Beese Fulmer Investment Management Inc. Purchases 12,078 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences at Barclays: Strategic Growth Focus - Investing.com
Edwards Lifesciences at Barclays Conference: Strategic Growth Focus By Investing.com - Investing.com Canada
Edwards Lifesciences at Barclays Conference: Strategic Growth Focus - Investing.com
Korea Investment CORP Purchases 46,317 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Edwards Lifesciences jumps 3.21% with $400M traded, placing 368th in volume; revenue growth exceeds earnings shortfall - Bitget
Is Edwards Lifesciences Stock Outperforming the S&P 500? - Barchart
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):